LONDON – Actelion SA reinforced its defenses against the unwanted attention of activist investor Elliott Advisors, which is seeking to replace the company's board with six of its own nominees. (BioWorld International)

Extending a partnership that dates back to 1999, Genfit, of Lille, France, has inked an agreement with Sanofi-Aventis SA, of Paris, to pursue therapies for the treatment of metabolic disorders. (BioWorld International)